drugset / Trial / NCT01306409

Neocytolysis in the Treatment of Renal Anemia With Erythropoieses Stimulating Agents (ESA)

NCT01306409

RandomizedCrossoverOpen-labelBasic science

Summary

The purpose of this study is to gain information on reticulocyte neocytolysis in patients treated with ESA with regard to different types of ESA.

Timeline

Start
2011-01
Primary completion
2011-07
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Darbepoetin alfa Protein / enzyme biologic
Subject epoetin alfa Protein / enzyme biologic
Subject methoxy polyethylene glycol-epoetin beta Protein / enzyme biologic

Indications